DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-6,549 Cr | ₹-5,808 Cr | ₹-4,028 Cr | ₹-4,137 Cr | ₹-2,639 Cr |
What is the latest Cash Flow from Investing Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-6,549 Cr |
| Mar2025 | ₹-5,808 Cr |
| Mar2024 | ₹-4,028 Cr |
| Mar2023 | ₹-4,137 Cr |
| Mar2022 | ₹-2,639 Cr |
How is Cash Flow from Investing Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-6,549 Cr | Negative | |
| Mar2025 | ₹-5,808 Cr | Negative | |
| Mar2024 | ₹-4,028 Cr | Negative | |
| Mar2023 | ₹-4,137 Cr | Negative | |
| Mar2022 | ₹-2,639 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹100,330.9 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| MANKIND PHARMA | ₹100,364.0 Cr | 6.2% | 1.9% | -10.3% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 4.5% |
1.8% |
-10% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses